Patents by Inventor Warren Wasiewski

Warren Wasiewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND THREAPEUTIC COMBINATIONS FOR TREATING IDIOPATHIC INTRACRANIAL HYPERTENSION AND CLUSTER HEADACHES
    Publication number: 20240131116
    Abstract: Methods and therapeutic combinations are provided for treating idiopathic intracranial hypertension (IIH) and cluster headache, comprising administering a somatostatin mimetic such as octreotide formulated for direct nose-to-brain administration, and a carbonic anhydrase inhibitor such as topiramate or acetazolamide, at a dose level and/or dosing regimen lower than effective when administered alone.
    Type: Application
    Filed: February 23, 2022
    Publication date: April 25, 2024
    Applicant: NBO PHARMA LLC
    Inventors: Fredric D. PRICE, Barry R. FRANKEL, Dorian BEVEC, Warren WASIEWSKI
  • TREHALOSE FORMULATIONS AND USES THEREOF
    Publication number: 20220387463
    Abstract: The present disclosure relates to methods of treating or alleviating one or more symptoms of mucopolysaccharidoses in a subject, via administering a trehalose formulation to the subject.
    Type: Application
    Filed: September 29, 2020
    Publication date: December 8, 2022
    Inventors: Raj Mehra, Warren Wasiewski, Gopal Krishna
  • METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB
    Publication number: 20220259305
    Abstract: The disclosure provides methods of treating refractory myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody. In certain embodiments, the patient achieves and maintains the status of improved or MM according to the MGFA Post-Intervention Status.
    Type: Application
    Filed: August 4, 2020
    Publication date: August 18, 2022
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Jing Jing Wang, Warren Wasiewski, Fanny O'Brien, Kenji Fujita